SEC Filing Summary: Landec Corporation (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Landec Corporation on January 3, 2012. The filing serves to announce the company's consolidated financial results for the second quarter and first half of fiscal year 2012. The detailed results are contained in a press release attached as Exhibit 99.1.
Note: The request metadata lists "LIFECORE BIOMEDICAL, INC.", but the filing text explicitly identifies the registrant as "LANDEC CORPORATION". This summary reflects the entity named in the filing text.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being contained within the attached press release (Exhibit 99.1), which is not included in the provided source text.
Material Changes
The filing does not detail specific material changes or comparative figures versus prior periods within the text body. It solely references the issuance of the press release containing the results.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies. It includes a standard disclaimer stating that the information furnished in this report and Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the specific financial results (revenue, net income, EPS) by reviewing the attached Exhibit 99.1 (Press Release dated January 3, 2012).
- Confirm the fiscal year end date for Landec Corporation to ensure accurate period comparison.
- Review the full press release for any management commentary on operational trends or future outlook not captured in this 8-K summary.
- Check subsequent filings for any updates or corrections to the preliminary results announced in this report.